Functional analysis of LDLR promoter and 5′ UTR mutations in subjects with clinical diagnosis of familial hypercholesterolemia

Familial hypercholesterolemia (FH) is a dominant disorder due to mutations in the LDLR gene. Several mutations in the LDLR promoter are associated with FH. Screening of 3,705 Spanish FH patients identified 10 variants in the promoter and 5′ UTR. Here, we analyse the functionality of six newly identi...

Full description

Saved in:
Bibliographic Details
Published inHuman mutation Vol. 32; no. 8; pp. 868 - 872
Main Authors De Castro-Orós, Isabel, Pampín, Sandra, Bolado-Carrancio, Alfonso, De Cubas, Aguirre, Palacios, Lourdes, Plana, Nuria, Puzo, Jose, Martorell, Esperanza, Stef, Marianne, Masana, Luis, Civeira, Fernando, Rodríguez-Rey, Jose Carlos, Pocoví, Miguel
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.08.2011
John Wiley & Sons, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Familial hypercholesterolemia (FH) is a dominant disorder due to mutations in the LDLR gene. Several mutations in the LDLR promoter are associated with FH. Screening of 3,705 Spanish FH patients identified 10 variants in the promoter and 5′ UTR. Here, we analyse the functionality of six newly identified LDLR variants. Mutations located in the LDLR promoter regulatory elements R2 and R3 (c.−155_‐150delACCCCinsTTCTGCAAACTCCTCCC, c.−136C>G, c.−140C>G, and c.−140C>T) resulted in 6 to 15% residual activity in reporter expression experiments and changes in nuclear protein binding affinity compared to wild type. No reduction was observed when cells were transfected with c.−208T, c.−88A, and c.−36G mutant fragments. Our results indicate that mutations localized in R2 and R3 are associated with hypercholesterolemia, whereas mutations outside the LDLR response elements are not a cause of FH. This data emphasizes the importance of functional analysis of variants in the LDLR promoter to determine their association with the FH phenotype.Hum Mutat 32:1–5, 2011. © 2011 Wiley‐Liss, Inc.
Bibliography:Communicated by Mario Tosi
ArticleID:HUMU21520
CIBERER
ark:/67375/WNG-7JS62B4X-M
istex:B9262FAA01B8D83DD7355D3C38A551AABF407A90
Grants from the Spanish Ministry of Health FIS - No. PS09/00665; PS09/00962; PS09/000673; RETIC RD06/0014/0029 (RECAVA)
Aragon Workers Health Study (AWHS)
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ISSN:1059-7794
1098-1004
1098-1004
DOI:10.1002/humu.21520